Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hobisch

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|January 1, 1997
Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomasI E Eder, A Stenzl, A Hobisch, et al.
Kidney International. Supplement|November 1, 1994
Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injuryW Pfaller, U Thorwartl, M Nevinny-Stickel, et al.
Urologia Internationalis|October 12, 2000
Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer modelA Hobisch, J Hoffmann, L Lambrinidis, et al.
The Prostate|January 1, 1993
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reactionZ Culig, H Klocker, J Eberle, et al.
The Prostate|August 4, 1998
Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinomaZ Culig, A Hittmair, A Hobisch, et al.
The Prostate|April 16, 1998
Expression, structure, and function of androgen receptor in advanced prostatic carcinomaZ Culig, A Hobisch, A Hittmair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotypeA Hobisch, R Ramoner, D Fuchs, et al.
World Journal of Urology|January 1, 1995
Activation of the androgen receptor by polypeptide growth factors and cellular regulatorsZ Culig, A Hobisch, M V Cronauer, et al.
Cancer Research|October 27, 1998
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptorA Hobisch, I E Eder, T Putz, et al.
Cancer Genetics and Cytogenetics|May 18, 1999
Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classificationI Verdorfer, A Hobisch, A Hittmair, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|January 1, 1997
Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomasI E Eder, A Stenzl, A Hobisch, et al.
Kidney International. Supplement|November 1, 1994
Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injuryW Pfaller, U Thorwartl, M Nevinny-Stickel, et al.
Urologia Internationalis|October 12, 2000
Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer modelA Hobisch, J Hoffmann, L Lambrinidis, et al.
The Prostate|January 1, 1993
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reactionZ Culig, H Klocker, J Eberle, et al.
The Prostate|August 4, 1998
Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinomaZ Culig, A Hittmair, A Hobisch, et al.
The Prostate|April 16, 1998
Expression, structure, and function of androgen receptor in advanced prostatic carcinomaZ Culig, A Hobisch, A Hittmair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotypeA Hobisch, R Ramoner, D Fuchs, et al.
World Journal of Urology|January 1, 1995
Activation of the androgen receptor by polypeptide growth factors and cellular regulatorsZ Culig, A Hobisch, M V Cronauer, et al.
Cancer Research|October 27, 1998
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptorA Hobisch, I E Eder, T Putz, et al.
Cancer Genetics and Cytogenetics|May 18, 1999
Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classificationI Verdorfer, A Hobisch, A Hittmair, et al.
Pageof 8